Publication Results

Generate Report

Add publications by marking their checkboxes, or

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.

Winchester DA,  Gurel B,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Thompson IM,  Xu J,  Zheng SL,  Lucia MS,  Lippman SM,  Parnes HL,  Isaacs WB,  Drake CG,  De Marzo AM,  Platz EA
Prostate 2016 May;76(6):565-74
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26771888
PMC ID: PMC4841624
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Murtola TJ,  Gurel B,  Umbehr M,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Kristal AR,  Parnes HL,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Barber JR,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2016 Mar;25(3):463-9
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26715424
PMC ID: PMC4779655
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Winchester Danyelle A.,  Till Cathee,  Goodman Phyllis J.,  Tangen Catherine M.,  Santella Regina M.,  Johnson-Pais Teresa L.,  Leach Robin J.,  Xu Jianfeng,  Zheng S. Lilly,  Thompson Ian M.,  Lucia M. Scott,  Lippmann Scott M.,  Parnes Howard L.,  Dluzniewski Paul J.,  Isaacs William B.,  De Marzo Angelo M.,  Drake Charles G.,  Platz Elizabeth A.
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 4605
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe FL,  Appleby PN,  Travis RC,  Barnett M,  Brasky TM,  Bueno-de-Mesquita HB,  Chajes V,  Chavarro JE,  Chirlaque MD,  English DR,  Gibson RA,  Giles GG,  Goodman GE,  Henning SM,  Kaaks R,  King IB,  Kolonel LN,  Kristal AR,  Neuhouser ML,  Park SY,  Severi G,  Siddiq A,  Stampfer MJ,  Stattin P,  Tangen CM,  Tjønneland A,  Trichopoulos D,  Tumino R,  Wilkens LR,  Key TJ,  Allen NE,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2014 Sep;106(9)
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25210201
PMC ID: PMC4188122
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER,  Arnold KB,  Moinpour CM,  Burton-Chase AM,  Tangen CM,  Probstfield JF,  See WA,  Lieber MM,  Caggiano V,  Moody-Thomas S,  Szczepanek C,  Ryan A,  Carlin S,  Hill S,  Goodman PJ,  Padberg RM,  Minasian LM,  Meyskens FL,  Thompson IM Jr
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Community Clinical Oncology Program ;  Prostate and Urologic Cancer
PubMed ID: 25028457
PMC ID: PMC4119542
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

Platz EA,  Tangen CM,  Goodman PJ,  Till C,  Parnes HL,  Figg WD,  Albanes D,  Neuhouser ML,  Klein EA,  Lucia MS,  Thompson IM Jr,  Kristal AR
J Urol 2014 Aug;192(2):379-84
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 24518774
PMC ID: PMC4104140
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Schenk JM,  Till CA,  Tangen CM,  Goodman PJ,  Song X,  Torkko KC,  Kristal AR,  Peters U,  Neuhouser ML
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1484-93
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25085836
PMC ID: PMC4120235
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Figg WD,  Chau CH,  Price DK,  Till C,  Goodman PJ,  Cho Y,  Varella-Garcia M,  Reichardt JK,  Tangen CM,  Leach RJ,  van Bokhoven A,  Thompson IM,  Lucia MS
Urology 2014 Jul;84(1):127-31
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24824408
PMC ID: PMC4077907
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP,  Hoefler J,  Bock S,  Goodman PJ,  Vickers A,  Hernandez J,  Sokoll LJ,  Sanda MG,  Wei JT,  Leach RJ,  Thompson IM
Urology 2014 Jun;83(6):1362-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24862395
PMC ID: PMC4035700
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Gurel B,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Tangen CM,  Kristal AR,  Parnes HL,  Hoque A,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2014 May;23(5):847-56
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 24748218
PMC ID: PMC4012292
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Survival in the prostate cancer prevention trial.

Tangen CM,  Goodman PJ,  Thompson IM Jr
N Engl J Med 2013 Nov 14;369(20):1968
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24224632
PMC ID: PMC4927191
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score.

Ankerst DP,  Till C,  Boeck A,  Goodman PJ,  Tangen CM,  Thompson IM
Urology 2013 Nov;82(5):1076-81
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24055241
PMC ID: PMC3874369
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

Schenk JM,  Hunter-Merrill R,  Zheng Y,  Etzioni R,  Gulati R,  Tangen C,  Thompson IM,  Kristal AR
Am J Epidemiol 2013 Sep 1;178(5):741-51
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 23813705
PMC ID: PMC3755644
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Long-term survival of participants in the prostate cancer prevention trial.

Thompson IM Jr,  Goodman PJ,  Tangen CM,  Parnes HL,  Minasian LM,  Godley PA,  Lucia MS,  Ford LG
N Engl J Med 2013 Aug 15;369(7):603-10
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 23944298
PMC ID: PMC4141537
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.

Vickers AJ,  Sjoberg DD,  Ankerst DP,  Tangen CM,  Goodman PJ,  Thompson IM Jr
Cancer 2013 Aug 15;119(16):3007-11
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 23720006
PMC ID: PMC3735626
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator.

Ankerst DP,  Till C,  Boeck A,  Goodman P,  Tangen CM,  Feng Z,  Partin AW,  Chan DW,  Sokoll L,  Kagan J,  Wei JT,  Thompson IM
J Urol 2013 Jul;190(1):70-6
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 23313212
PMC ID: PMC3708069
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Prostate cancer prevention: strategies for agent development.

Parnes HL,  House MG,  Tangrea JA
Curr Opin Oncol 2013 May;25(3):242-51
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 23518594
PMC ID: not available
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials.

Pinsky PF,  Black A,  Grubb R,  Crawford ED,  Andriole G,  Thompson I,  Parnes H
Cancer 2013 Feb 1;119(3):593-601
Major Program(s) or Research Group(s): Early Detection ;  Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic CancerProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 22893105
PMC ID: PMC3502695
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.

Neuhouser ML,  Platz EA,  Till C,  Tangen CM,  Goodman PJ,  Kristal A,  Parnes HL,  Tao Y,  Figg WD,  Lucia MS,  Hoque A,  Hsing AW,  Thompson IM,  Pollak M
Cancer Prev Res (Phila) 2013 Feb;6(2):91-9
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 23315596
PMC ID: PMC3565024
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.

Kristal AR,  Till C,  Tangen CM,  Goodman PJ,  Neuhouser ML,  Stanczyk FZ,  Chu LW,  Patel SK,  Thompson IM,  Reichardt JK,  Hoque A,  Platz EA,  Figg WD,  Van Bokhoven A,  Lippman SM,  Hsing AW
Cancer Epidemiol Biomarkers Prev 2012 Oct;21(10):1823-32
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 22879203
PMC ID: PMC3467348
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Health-related quality-of-life findings for the prostate cancer prevention trial.

Moinpour CM,  Darke AK,  Donaldson GW,  Cespedes D,  Johnson CR,  Ganz PA,  Patrick DL,  Ware JE Jr,  Shumaker SA,  Meyskens FL,  Thompson IM Jr
J Natl Cancer Inst 2012 Sep 19;104(18):1373-85
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 22972968
PMC ID: PMC3529595
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Sutcliffe S,  Till C,  Gaydos CA,  Jenkins FJ,  Goodman PJ,  Hoque AM,  Hsing AW,  Thompson IM,  Zenilman JM,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Causes Control 2012 Sep;23(9):1511-8
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 22810146
PMC ID: PMC3433040
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Finasteride reduces the risk of incident clinical benign prostatic hyperplasia.

Parsons JK,  Schenk JM,  Arnold KB,  Messer K,  Till C,  Thompson IM,  Kristal AR,  Prostate Cancer Prevention Trial,  Urologic Diseases in America Project
Eur Urol 2012 Aug;62(2):234-41
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 22459892
PMC ID: PMC4059403
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Schenk JM,  Calip GS,  Tangen CM,  Goodman P,  Parsons JK,  Thompson IM,  Kristal AR
Am J Epidemiol 2012 Jul 15;176(2):156-63
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 22759721
PMC ID: PMC3493197
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Vickers AJ
J Natl Cancer Inst 2011 Nov 2;103(21):1635-6
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21926376
PMC ID: not available
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Tang L,  Yao S,  Till C,  Goodman PJ,  Tangen CM,  Wu Y,  Kristal AR,  Platz EA,  Neuhouser ML,  Stanczyk FZ,  Reichardt JK,  Santella RM,  Hsing A,  Hoque A,  Lippman SM,  Thompson IM,  Ambrosone CB
Carcinogenesis 2011 Oct;32(10):1500-6
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21771722
PMC ID: PMC3179424
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.

Yao S,  Till C,  Kristal AR,  Goodman PJ,  Hsing AW,  Tangen CM,  Platz EA,  Stanczyk FZ,  Reichardt JK,  Tang L,  Neuhouser ML,  Santella RM,  Figg WD,  Price DK,  Parnes HL,  Lippman SM,  Thompson IM,  Ambrosone CB,  Hoque A
Cancer Causes Control 2011 Aug;22(8):1121-31
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 21667068
PMC ID: PMC3139891
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Brasky TM,  Till C,  White E,  Neuhouser ML,  Song X,  Goodman P,  Thompson IM,  King IB,  Albanes D,  Kristal AR
Am J Epidemiol 2011 Jun 15;173(12):1429-39
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21518693
PMC ID: PMC3145396
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

Schenk JM,  Kristal AR,  Arnold KB,  Tangen CM,  Neuhouser ML,  Lin DW,  White E,  Thompson IM
Am J Epidemiol 2011 Jun 15;173(12):1419-28
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21540324
PMC ID: PMC3276227
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Kristal AR,  Till C,  Platz EA,  Song X,  King IB,  Neuhouser ML,  Ambrosone CB,  Thompson IM
Cancer Epidemiol Biomarkers Prev 2011 Apr;20(4):638-46
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21335507
PMC ID: PMC3070045
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Vickers AJ,  Till C,  Tangen CM,  Lilja H,  Thompson IM
J Natl Cancer Inst 2011 Mar 16;103(6):462-9
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 21350221
PMC ID: PMC3057983
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

Goodman PJ,  Tangen CM,  Kristal AR,  Thompson IM,  Lucia MS,  Platz EA,  Figg WD,  Hoque A,  Hsing A,  Neuhouser ML,  Parnes HL,  Reichardt JK,  Santella RM,  Till C,  Lippman SM
Cancer Prev Res (Phila) 2010 Dec;3(12):1523-33
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 21149329
PMC ID: PMC3058741
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.

Price DK,  Chau CH,  Till C,  Goodman PJ,  Baum CE,  Ockers SB,  English BC,  Minasian L,  Parnes HL,  Hsing AW,  Reichardt JK,  Hoque A,  Tangen CM,  Kristal AR,  Thompson IM,  Figg WD
J Urol 2010 Dec;184(6):2297-302
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 20952028
PMC ID: PMC3930175
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.

Thompson IM,  Ankerst DP,  Tangen CM
J Natl Cancer Inst 2010 Sep 8;102(17):1299-301
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20724727
PMC ID: PMC2935478
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Kristal AR,  Arnold KB,  Neuhouser ML,  Goodman P,  Platz EA,  Albanes D,  Thompson IM
Am J Epidemiol 2010 Sep 1;172(5):566-77
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20693267
PMC ID: PMC2950820
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Baker SG,  Darke AK,  Pinsky P,  Parnes HL,  Kramer BS
Biostatistics 2010 Jul;11(3):413-8
Major Program(s) or Research Group(s): Prostate and Urologic CancerBiometry ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 20173101
PMC ID: PMC2883301
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.

Platz EA,  Sutcliffe S,  De Marzo AM,  Drake CG,  Rifai N,  Hsing AW,  Hoque A,  Neuhouser ML,  Goodman PJ,  Kristal AR
Cancer Causes Control 2010 Jun;21(6):847-51
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20135215
PMC ID: PMC3010861
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.

Kristal AR,  Price DK,  Till C,  Schenk JM,  Neuhouser ML,  Ockers S,  Lin DW,  Thompson IM,  Figg WD
Prostate 2010 May 1;70(6):584-90
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19938041
PMC ID: PMC3904425
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.

Hoque A,  Ambrosone CB,  Till C,  Goodman PJ,  Tangen C,  Kristal A,  Lucia S,  Wang Q,  Kappil M,  Thompson I,  Hsing AW,  Parnes H,  Santella RM
Cancer Prev Res (Phila) 2010 Apr;3(4):478-83
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 20332306
PMC ID: PMC2853720
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Schenk JM,  Kristal AR,  Neuhouser ML,  Tangen CM,  White E,  Lin DW,  Kratz M,  Thompson IM
Am J Epidemiol 2010 Mar 1;171(5):571-82
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20142396
PMC ID: PMC2842217
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Neuhouser ML,  Till C,  Kristal A,  Goodman P,  Hoque A,  Platz EA,  Hsing AW,  Albanes D,  Parnes HL,  Pollak M
Cancer Prev Res (Phila) 2010 Mar;3(3):279-89
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 20179296
PMC ID: PMC3846551
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Editorial comment.

Thompson IM
Urology 2010 Mar;75(3):509-10
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20211359
PMC ID: PMC2896285
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT) ;  Prostate Cancer Prevention Trial (PCPT)

Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Sutcliffe S,  Viscidi RP,  Till C,  Goodman PJ,  Hoque AM,  Hsing AW,  Thompson IM,  Zenilman JM,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2010 Feb;19(2):614-8
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 20142255
PMC ID: PMC2820385
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies.

Musumeci L,  Arthur JW,  Cheung FS,  Hoque A,  Lippman S,  Reichardt JK
Hum Mutat 2010 Jan;31(1):67-73
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19877174
PMC ID: PMC2797835
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Platz EA,  Till C,  Goodman PJ,  Parnes HL,  Figg WD,  Albanes D,  Neuhouser ML,  Klein EA,  Thompson IM Jr,  Kristal AR
Cancer Epidemiol Biomarkers Prev 2009 Nov;18(11):2807-13
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 19887582
PMC ID: PMC2877916
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.

Schenk JM,  Kristal AR,  Neuhouser ML,  Tangen CM,  White E,  Lin DW,  Thompson IM
Prostate 2009 Sep 1;69(12):1303-11
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19475640
PMC ID: PMC2838168
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Gong Z,  Kristal AR,  Schenk JM,  Tangen CM,  Goodman PJ,  Thompson IM
Cancer 2009 Aug 15;115(16):3661-9
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19598210
PMC ID: PMC2739798
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Chemoprevention of prostate cancer.

Thompson IM,  Tangen CM,  Goodman PJ,  Lucia MS,  Klein EA
J Urol 2009 Aug;182(2):499-507; discussion 508
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19524966
PMC ID: not available
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.

Sutcliffe S,  Alderete JF,  Till C,  Goodman PJ,  Hsing AW,  Zenilman JM,  De Marzo AM,  Platz EA
Int J Cancer 2009 May 1;124(9):2082-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 19117055
PMC ID: PMC2682694
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Development of the Prostate Cancer Prevention Trial prostate cancer risk calculator.

Ankerst DP,  Thompson IM Jr
2009
Ankerst DP,  Thompson IM Jr,  Tangen CM
Prostate Cancer Screening
Current Clinical Urology
ISBN: not available
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT) ;  Prostate Cancer Prevention Trial (PCPT)